Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Novel pressure relieving and sensing mattress and an intelligent control system that predicts and prevents pressure ulcers in bedridden patients

Ziel

ReQbo is developing a disruptive system for preventing pressure ulcers (PU) in bedridden patients by intelligently and
continuously assessing a personalized risk score for each patient. This system is the first market solution offering active
preventive care, instead of the reactive care that is enabled by competing technologies. Accordingly, the system will be
capable of contributing to a steep reduction in PU incidence in long-term care units, both in hospitals and nursing homes.
Treating pressure ulcers is very costly, accounting for more than €20 billion per year supported by EU public healthcare
systems. Prevention and early detection are the main priorities to reduce this current healthcare burden. Despite
improvements in healthcare systems and technologies, patients are still at risk of developing pressure ulcers, because of
ineffective and incomplete routine care to assign preventive measures. With current technologies and clinical practices,
patients in need of prevention cannot be accurately and reliably detected, which lead to PU development. While the
treatments options are well established once a patient has been diagnosed with high PU-risk, the method for assessing that
risk has not evolved significantly in 20 years.
In order to tackle this challenge, ReQbo has developed and patented its Qone system: a pressure relieving mattress, with
integrated temperature and pressure mapping sensors, that synchronizes data with a highly accurate screening algorithm.
This algorithm assesses a PU risk score based on individual patient parameters and a long-term record of how pressure and
temperature have been distributed in the patient’s body, allowing a reduction of approximately 75% on the overall number of
new pressure ulcers in bedridden patients. The result of each risk score assessment is communicated wirelessly to the
accompanying app and to the hospital monitoring system in order to inform the caretaker that a preventive measure needs to
be implemented.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Finanzierungsplan

SME-1 - SME instrument phase 1

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) H2020-SMEInst-2016-2017

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

REQBO APS
Netto-EU-Beitrag
€ 50 000,00
Adresse
PALLE JUUL-JENSENS BOULEVARD 82
8200 AARHUS N
Dänemark
KMU
Ja
Region
Danmark Midtjylland Østjylland
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 71 429,00